Blackstone Inc. is investing as much as $250 million in U.K. biotechnology company Autolus Therapeutics PLC to fund the final stages of development of a new therapy to treat a serious form of leukemia, the companies said.

from MarketWatch.com - Top Stories https://ift.tt/308Juqr
via IFTTT
from MarketWatch.com - Top Stories https://ift.tt/308Juqr
via IFTTT
Kommentare
Kommentar veröffentlichen